Wave Life Sciences Ltd. - Ordinary Shares (WVE): Price and Financial Metrics
Today's Latest Price: $7.07 USD
Oct 30 4:00pm Add WVE to Watchlist Sign Up
WVE Stock Summary Wave Life Sciences Ltd's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 3.52% of US listed stocks. WVE's price/sales ratio is 20.59; that's higher than the P/S ratio of 92.72% of US stocks. As for revenue growth, note that WVE's revenue has grown -33.3% over the past 12 months; that beats the revenue growth of just 7.78% of US companies in our set. Stocks with similar financial metrics, market capitalization, and price volatility to Wave Life Sciences Ltd are VBLT, SYBX, KALV, NTLA, and FIXX. Visit WVE's SEC page to see the company's official filings. To visit the company's web site, go to www.wavelifesciences.com.
WVE Price/Volume Stats
Wave Life Sciences Ltd. - Ordinary Shares (WVE) Company Bio
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company was founded in 2012 and is based in Simgapore.
WVE Latest News Stream
All News Types
Commentary Corp. News Earnings IPOs Mgmt Change New Coverage (Bullish) Product News PT Lowered PT Raised PT Set (Bullish) Rating Reiterated (Bullish) Resumes Coverage (Bullish) Stock Offering
Loading, please wait...
Latest WVE News From Around the Web
Below are the latest news stories about Wave Life Sciences Ltd that investors may wish to consider to help them evaluate WVE as an investment opportunity.
The following slide deck was published by Wave Life Sciences Ltd. in conjunction with this event....
Shares of WAVE Life Sciences (NASDAQ:WVE) moved higher by 1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per …
CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to…
Wave Life Sciences (WVE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors need to pay close attention to Wave Life Sciences (WVE) stock based on the movements in the options market lately.
Read More 'WVE' Stories Here
WVE Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 1.3035 seconds.